IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
In: Investigator-Initiated Trial of the LSD1 Inhibitor IMG-7289 for the Treatment of Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) That Have Failed at Least One Standard Therapy
Online
report
Titel: |
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
|
---|---|
Autor/in / Beteiligte Person: | Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) ; Terrence J Bradley, MD, Assistant Professor |
Link: | |
Quelle: | Investigator-Initiated Trial of the LSD1 Inhibitor IMG-7289 for the Treatment of Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) That Have Failed at Least One Standard Therapy |
Medientyp: | report |
Sonstiges: |
|